Sanofi (SNY)
Sanofi Statistics
Share Statistics
Sanofi has 2.48B shares outstanding. The number of shares has increased by -2.3% in one year.
| Shares Outstanding | 2.48B |
| Shares Change (YoY) | -2.3% |
| Shares Change (QoQ) | -1.9% |
| Owned by Institutions (%) | 21.07% |
| Shares Floating | 2.48B |
| Failed to Deliver (FTD) Shares | 110.14K |
| FTD / Avg. Volume | 4.18% |
Short Selling Information
The latest short interest is 5.29M, so 0.21% of the outstanding shares have been sold short.
| Short Interest | 5.29M |
| Short % of Shares Out | 0.21% |
| Short % of Float | 0.21% |
| Short Ratio (days to cover) | 2.17 |
Valuation Ratios
The PE ratio is 20.99 and the forward PE ratio is 11.72. Sanofi's PEG ratio is 6.96.
| PE Ratio | 20.99 |
| Forward PE | 11.72 |
| PS Ratio | 2.64 |
| Forward PS | 2.2 |
| PB Ratio | 1.51 |
| P/FCF Ratio | 19.83 |
| PEG Ratio | 6.96 |
Enterprise Valuation
Sanofi has an Enterprise Value (EV) of 68.82B.
| EV / Sales | 1.55 |
| EV / EBITDA | 6.24 |
| EV / EBIT | 7.58 |
| EV / FCF | 11.69 |
Financial Position
The company has a current ratio of 1.46, with a Debt / Equity ratio of 0.23.
| Current Ratio | 1.46 |
| Quick Ratio | 1.14 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | 1.62 |
| Debt / FCF | 3.04 |
| Interest Coverage | 9.68 |
Financial Efficiency
Return on Equity is 7.17% and Return on Invested Capital is 5.5%.
| Return on Equity | 7.17% |
| Return on Assets | 4.19% |
| Return on Invested Capital | 5.5% |
| Revenue Per Employee | $534.35K |
| Profits Per Employee | $67.09K |
| Employee Count | 82,878 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 1.4 |
Taxes
| Income Tax | 1.2B |
| Effective Tax Rate | 17.98% |
Stock Price Statistics
The stock price has increased by 12.49% in the last 52 weeks. The beta is 0.46, so Sanofi's price volatility has been higher than the market average.
| Beta | 0.46 |
| 52-Week Price Change | 12.49% |
| 50-Day Moving Average | 55.26 |
| 200-Day Moving Average | 52.72 |
| Relative Strength Index (RSI) | 38.49 |
| Average Volume (20 Days) | 2.63M |
Income Statement
In the last 12 months, Sanofi had revenue of 44.29B and earned 5.56B in profits. Earnings per share was 4.44.
| Revenue | 44.29B |
| Gross Profit | 31.08B |
| Operating Income | 7.25B |
| Net Income | 5.56B |
| EBITDA | 11.03B |
| EBIT | 7.45B |
| Earnings Per Share (EPS) | 4.44 |
Balance Sheet
The company has 7.44B in cash and 17.91B in debt, giving a net cash position of -10.46B.
| Cash & Cash Equivalents | 7.44B |
| Total Debt | 17.91B |
| Net Cash | -10.46B |
| Retained Earnings | 0 |
| Total Assets | 132.8B |
| Working Capital | 13.43B |
Cash Flow
In the last 12 months, operating cash flow was 9.08B and capital expenditures -3.19B, giving a free cash flow of 5.89B.
| Operating Cash Flow | 9.08B |
| Capital Expenditures | -3.19B |
| Free Cash Flow | 5.89B |
| FCF Per Share | 4.7 |
Margins
Gross margin is 70.18%, with operating and profit margins of 16.38% and 12.55%.
| Gross Margin | 70.18% |
| Operating Margin | 16.38% |
| Pretax Margin | 15.12% |
| Profit Margin | 12.55% |
| EBITDA Margin | 24.91% |
| EBIT Margin | 16.38% |
| FCF Margin | 13.29% |
Dividends & Yields
SNY pays an annual dividend of $4.24, which amounts to a dividend yield of 4.51%.
| Dividend Per Share | $4.24 |
| Dividend Yield | 4.51% |
| Dividend Growth (YoY) | 7.73% |
| Payout Ratio | 177.32% |
| Earnings Yield | 4.76% |
| FCF Yield | 10.09% |
Analyst Forecast
The average price target for SNY is $62.5, which is 15.8% higher than the current price. The consensus rating is "Buy".
| Price Target | $62.5 |
| Price Target Difference | 15.8% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on Sep 30, 2013. It was a forward split with a ratio of 5:1.
| Last Split Date | Sep 30, 2013 |
| Split Type | forward |
| Split Ratio | 5:1 |
Scores
| Altman Z-Score | 2.12 |
| Piotroski F-Score | 7 |